How rare is isolated rheumatic tricuspid valve disease? by Mustafa, Edme R. et al.
Journal of Mind and Medical Sciences 
Volume 7 Issue 1 Article 21 
2020 
How rare is isolated rheumatic tricuspid valve disease? 
Edme R. Mustafa 
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF CARDIOLOGY, CRAIOVA, 
ROMANIA 
Octavian Istrătoaie 
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF CARDIOLOGY, CRAIOVA, 
ROMANIA 
Roxana Mandia 
CRAIOVA EMERGENCY HOSPITAL, CRAIOVA, ROMANIA 
Georgică C. Târtea 
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF PHYSIOLOGY, CRAIOVA, 
ROMANIA 
Cristina Florescu 
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF CARDIOLOGY, CRAIOVA, 
ROMANIA 
Follow this and additional works at: https://scholar.valpo.edu/jmms 
 Part of the Cardiology Commons, Internal Medicine Commons, and the Rheumatology Commons 
Recommended Citation 
Mustafa, Edme R.; Istrătoaie, Octavian; Mandia, Roxana; Târtea, Georgică C.; and Florescu, Cristina (2020) 
"How rare is isolated rheumatic tricuspid valve disease?," Journal of Mind and Medical Sciences: Vol. 7 : 
Iss. 1 , Article 21. 
DOI: 10.22543/7674.71.P128132 
Available at: https://scholar.valpo.edu/jmms/vol7/iss1/21 
This Case Presentation is brought to you for free and open access by ValpoScholar. It has been accepted for 
inclusion in Journal of Mind and Medical Sciences by an authorized administrator of ValpoScholar. For more 
information, please contact a ValpoScholar staff member at scholar@valpo.edu. 
To cite this article: Edme R. Mustafa, Octavian Istrătoaie, Roxana Mandia, Georgică C. Târtea, Cristina Florescu. How rare is 
isolated rheumatic tricuspid valve disease? J Mind Med Sci. 2020; 7(1): 128-132. DOI: 10.22543/7674.71.P128132  
 
 Journal of Mind and Medical Sciences 
 
https://scholar.valpo.edu/jmms/  
https://proscholar.org/jmms/  
I S S N :  2 3 9 2 - 7 6 7 4  
 
 
 
 
How rare is isolated rheumatic tricuspid valve disease? 
 
Edme R. Mustafa1, Octavian Istrătoaie1, Roxana Mandia2, Georgică C. Târtea3, 
Cristina Florescu1 
 
1
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF CARDIOLOGY, CRAIOVA, ROMANIA 
2
CRAIOVA EMERGENCY HOSPITAL, CRAIOVA, ROMANIA 
3
CRAIOVA UNIVERSITY OF MEDICINE AND PHARMACY, DEPARTMENT OF PHYSIOLOGY, CRAIOVA, ROMANIA 
 
A B ST R AC T 
 
 
The incidence of rheumatic fever (RF) has markedly decreased in Europe 
since the beginning of the 20th century due to improved living conditions, 
early antibiotic therapy in streptococcal pharyngitis, and changes in 
serotypes of circulating streptococci. Isolated outbreaks of RF are still found 
in various parts of the world and the disease has changed its presentation 
with milder joint symptoms and subclinical carditis that make the correct 
diagnosis more difficult. Patients can present many years later with severe 
valve disease and significant disability. This article presents a case of 
isolated rheumatic tricuspid valve disease that presented with signs and 
symptoms of right heart failure and severe valve damage. Isolated 
involvement of the tricuspid valve is rarely found in rheumatic fever and a 
thorough differential diagnosis is needed.   
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Introduction  
The incidence of rheumatic fever (RF) and rheumatic 
heart disease has decreased in Europe in the last century 
due to improved living conditions, proper use of antibiotics 
in streptococcal pharyngitis, and changes in streptococcal 
serotypes. RF is a non-suppurative inflammation of 
connective tissue that occurs as a late complication of a 
pharyngeal infection caused by group A beta hemolytic 
streptococcus (GABHS) in predisposed individuals. It is an 
autoimmune disease, in which an intense humoral and 
cellular mediated immune response (activated against the 
streptococci) damages various organs. This is due to a 
molecular mimicry between M protein and N acetyl 
glucosamine from the bacterial wall and compounds like 
vimentin (from synovial tissue), myosin and tropomyosin 
(from myocardium), laminin (from heart valves), keratin 
(form skin), or lysogangliosides (found in subthalamic and 
caudal nuclei) of human host [1]. The disease occurs in 
young patients typically aged 5-15 years. Individuals 
expressing B cell alloantigen D8/17 or HLA- DR7 or HLA- 
D8/17 have an increased risk of RF [2]. The affected 
organs are represented by heart, joints, central nervous 
system, and skin. Heart involvement consists of the 
occurrence of pancarditis. The only long-term sequel of 
rheumatic fever is valve disease.  
The microscopic changes seen in rheumatic valvulitis 
vary over time; in the first weeks there is inflammatory cell 
infiltration, breakdown of collagen fibrils, edema, and later 
granuloma formation. The rheumatic granuloma is named 
Aschoff body. The Aschoff body has a central area of 
collagen necrosis surrounded by lymphocytes, 
macrophages, giant multinuclear cells, and fibroblasts.  
The granuloma will be replaced by a fibrous scar. Initial 
valve damage can expose intracellular proteins to the 
immune cells that will generate autoantibodies and lead to 
continuing low grade inflammation. Persisting 
inflammation and the trauma produced by the turbulent 
blood flow contribute to the severe valve damage seen 
many years after RF.         
Inflammation preferentially affects the mitral and 
aortic valves, possibly due to higher hemodynamic stress 
on valve tissue, while tricuspid and pulmonary valves are 
rarely involved. Although rare, isolated rheumatic 
tricuspid valve disease can cause severe heart failure. 
Edme R. Mustafa et al. 
 129 
Case Presentation 
A 59-year-old male presented to the emergency 
department for shortness of breath on mild exertion and 
palpitations, symptoms that began 3 weeks earlier. He is a 
chronic alcohol drinker but has no medical history. On 
physical examination, mild peripheral edema was present, 
breath sounds were abolished at both lung bases due to 
pleural effusions, arterial oxygen saturation (SaO2) was 
90%, heart rate was 130 beats/min with irregular heart 
sounds, and a systolic murmur grade  III/VI was heard in 
the 4-5th intercostal spaces on the left sternal border and 
accentuated with inspiration. Blood pressure was 130/80 
mmHg, jugular veins were distended, and the liver was 
enlarged and tender. 
Blood analysis showed a high NT proBNP value of 
2853 pg/ml, high D – dimer value of 2.86 µg/ml, normal 
troponin T, high value of liver enzymes (ASAT=90 U, 
ALAT= 48 U, gamma glutamyl transpeptidase= 417u), 
with slight increase in both direct and indirect bilirubin 
values; hepatic viral antigens were absent. Other blood 
analyses were in the normal range. 
ECG showed atrial fibrillation with fast heart rate (120 
bpm), a QRS axis of +900, incomplete right bundle branch 
block and QRS alternans in V1-V6 leads. Thoracic CT scan 
found bilateral pleural effusions in moderate amount and 
excluded pneumonia, lung tumor, or pulmonary embolism.  
Transthoracic echocardiography (TTE) showed 
significant structural changes in the tricuspid valve. 
Anterior and posterior cusps were thickened, calcified, and 
had restricted motion. Subvalvular chords were thickened. 
Structural changes caused severe regurgitation (effective 
regurgitant orifice area= 0.57 cm2, regurgitant volume= 45 
ml) and moderate stenosis (high diastolic gradient of 13/6 
mmHg which contributed to the high inflow accompanying 
severe regurgitation). Right chambers were dilated with 
right ventricle longitudinal systolic dysfunction (TAPSE= 
16mm, S’value = 10 cm/s) and with dilated inferior vena 
cava indicating increased pressure in the right atrium. 
These aspects are shown in figures 1-5.   
 
Figure 1. Apical 4 chambers (A4C) view- thickened 
tricuspid valve leaflets and dilated right heart chambers. 
A 3D exam could have better described valve anatomy 
including commissural fusion and could measure tricuspid 
valve area by planimetry but was not available.  
Small calcification spots were found on aortic cusps 
causing mild aortic regurgitation, aspect shown in figure 6. 
 
Figure 2. Parasternal short axis view- the anterior 
cusp of the tricuspid valve is thickened and calcified, 
chordae tendinae are thickened, right atrium is dilated 
and a calcification area is found on the aortic right 
coronary cusp.   
 
Figure 3. Right ventricular inflow view- the anterior 
and posterior cusps of the tricuspid valve have 
massive calcifications.   
 
Figure 4. A4C Color Doppler - severe tricuspid 
regurgitation. 
Figure 1 
Figure 2  
Figure 3 
Figure 4 
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Figure 5. A4C CWD - the envelope of right 
ventricular inflow with high gradients indicating  
severe tricuspid stenosis and the envelope of severe 
tricuspid regurgitation. 
 
Figure 6. Mild aortic regurgitation. 
 
Figure 7. ECG 
Mitral valve had no structural changes. The left 
ventricle had normal dimensions but diffuse hypokinesis 
and reduced ejection fraction (35%). A small amount of 
pericardial fluid was noticed. 
The patient was diagnosed with isolated rheumatic 
tricuspid valve disease (severe regurgitation and stenosis) 
and heart failure. Left ventricle systolic dysfunction could 
be toxic (alcohol) or due to tachycardia; other etiologies 
like myocarditis or ischemia were improbable. He was 
treated with beta-blocker, digoxin, diuretics, and anti-
coagulants. Edema and pleural effusions disappeared and 
patient’s condition improved; also, the value of liver 
enzymes became normal. The patient required surgical 
correction of the tricuspid valve disease.  
Rheumatic tricuspid valve disease should be 
differentiated from other diseases like carcinoid syndrome 
(which causes valve thickening with “frozen” aspect), 
congenital tricuspid regurgitation/stenosis (due to various 
anomalies of cusps like cleft or hypoplasia, anomalies of 
chordae like short, elongated or abnormally inserted,  
or anomalies of commissures COMMISSURAL 
ANOMALIES etc.), or valve damage due to drugs (which 
cause valve fibrosis), but calcifications are not seen in these 
etiologies [3]. Radiation therapy causes valve fibrosis and 
calcification but not commissural fusion. 
Discussions 
The incidence of rheumatic fever has decreased since 
the 1900s in many regions including Europe, due to 
improved living conditions, early diagnosis and therapy of 
pharyngitis, and change in streptococcal virulence. The 
disease has shown an unexpected revival as isolated 
outbreaks of RF caused by virulent serotypes reported 
worldwide. A recent review shows an increasing trend in 
RF incidence in the Americas and Western Pacific, in 
Eastern Mediterranean and Asia, a constant decrease in 
Africa, and a decrease in Europe. The prevalence of 
rheumatic heart disease is increasing in all parts of the 
world with the exception of Europe [2,3]. 
 Only 0.3-3% of patients with pharyngitis develop 
rheumatic fever, 40-60% of them will have carditis, and 
60% will develop rheumatic heart disease and have an 
increased risk of arrhythmia, embolic complications and 
heart failure [4].  
The diagnosis of rheumatic fever is done using the 
Jones criteria that have been modified several times over 
the last 6 decades. There are both major criteria (migratory 
polyarthritis, clinical or subclinical carditis, chorea, 
erythema marginatum and subcutaneous nodules) and 
minor criteria (polyarthralgia, fever, long PR interval, high 
value of inflammation markers, history of previous episode 
of RF or rheumatic heart disease). The third criterion is the 
proof of preceding GABHS infection provided by 
increasing titers of anti-streptococcal antibodies or 
isolation of GABHS in throat culture or positive rapid 
GABHS carbohydrate antigen test in a child. 
Echocardiography has a substantial contribution to the 
diagnosis of subclinical carditis. 
The 2015 AHA revision of Jones criteria clarified 
specific parameters. Low risk population is considered if 
there are fewer than 2 cases of RF per 100,000 school aged 
children per year and less than 1 case with rheumatic heart 
disease per 1000 population per year [5]. The classical 
algorithm for the diagnosis of RF remains unchanged for 
Figure 5 
Figure 6 
Figure 7 
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low risk populations: the need for the presence 2 major 
criteria, or 1 major and 2 minor criteria, together with the 
evidence of recent streptococcal infection. For recurrent 
RF, the presence of 3 minor criteria is also diagnostic. In 
moderate and high-risk populations, monoarthritis and 
polyarthralgia are major criteria, while monoarthralgia is 
considered a minor criteria. Fever should be more than 
38.50C in low risk and more than 380C in high risk 
populations. ESR should be more than 60 mm/h in low risk 
and more than 30 mm/h in moderate and high risk 
populations, while C reactive protein should be more than 
3mg/dl in all patients [5]. 
RF rarely affects right heart valves. Primary right heart 
valve disease is found in 1.2% of patients with valve 
disease according to Euro Heart Survey [6] and rheumatic 
etiology can comprise up to a third of cases. The 
prevalence of rheumatic tricuspid valve disease varies in 
different parts of the world. In India tricuspid valve disease 
was diagnosed in 9% of patients with rheumatic disease, 
the mean age of patients was 24.2± 13.6 years [7]. Half of 
the cases had combined stenosis and regurgitation and half 
had isolated regurgitation.  
In Europe, Bernal evaluated 328 patients with 
rheumatic tricuspid valve disease referred for surgery 
during a 30 year period and found that only 3.65% of cases 
had isolated tricuspid valve disease, while the majority had 
triple valve disease (60%) or double valve disease (33%), 
most commonly mitral and tricuspid disease [8]. Patients 
had a mean age of 51.3 ± 13.6years. The majority (72%) 
had tricuspid regurgitation. Valve repair was achieved in 
most cases (90.5%), and the in-hospital mortality was 7.6% 
[8].              
Our case is unusual because the patient did not have a 
classical episode of RF, the diagnosis was late when 
complications occurred and because of isolated tricuspid 
damage. The patient needed tricuspid valve replacement 
with a prosthesis. Data in the literature show that tricuspid 
valve replacement has a higher immediate and midterm 
mortality compared with valve repair (consisting of 
commissurotomy and flexible or suture annuloplasty). 
Recurrent tricuspid regurgitation is more common after 
valve repair. A recent review found similar percentages of 
patients with rheumatic tricuspid valve disease treated with 
valve repair or replacement [9].   
Both biological and mechanical prosthesis are good 
choices for the tricuspid valve, patients having similar 
early and late survival and similar re-operation rates. 
According to Rizzoli, the tricuspid valve makes no 
exception to the rule that patients older than 65-70 years 
benefit more from bio-prosthesis while younger ones from 
mechanical valves [10, 11]. 
Highlights 
✓ Although the incidence of rheumatic heart disease is 
decreasing, in practice rheumatic valve damage still 
presents in a variety of scenarios and the management 
of cases remains a challenge. 
✓ Transthoracic echocardiography has a key role in 
diagnosing tricuspid valve disease.  
Conclusions 
Rheumatic valve disease continues to cause significant 
morbidity despite health programs of early diagnosis and 
therapy of streptococcal infections. Isolated rheumatic 
tricuspid valve damage can cause severe heart failure.  
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